Literature DB >> 8733049

Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists.

D Mutton1, E Alberman, E B Hook.   

Abstract

Data from the National Down Syndrome Cytogenetic Register is used to describe the cytogenetics and epidemiology of registered cases. The register comprises notifications from cytogenetics laboratories in England and Wales. This report is of 5737 cases registered between 1989 and 1993: 2169 prenatal and 3436 postnatal diagnoses, and 132 spontaneous abortions. Eighty eight registrations were from multiple pregnancies. Ninety five percent had regular trisomy 21. In 4% there was a translocation, mostly Robertsonian t(14;21) or t(21;21). One percent were mosaics with one normal cell line. Mean maternal age was raised in free trisomy 21, but not in translocations. Where families had been investigated, about a third of translocations were inherited, six to seven times more often from the mother than the father. Associations between free trisomy 21 and structural chromosomal defects in the births were no more common than expected from newborn series. The overall sex ratio was raised (male to female: 1.23 to 1), and there was an excess of associated male sex chromosomal aneuploidy. However, in mosaics with one normal cell line the male to female ratio was 0.8 to 1, and in twins discordant for trisomy 21 there was also a female excess.

Entities:  

Mesh:

Year:  1996        PMID: 8733049      PMCID: PMC1050608          DOI: 10.1136/jmg.33.5.387

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  [Excess of males in trisomy 21 (author's transl)].

Authors:  A Bernheim; C Chastang; M de Heaulme; J de Grouchy
Journal:  Ann Genet       Date:  1979-06

2.  Results of first year (1989) of a national register of Down's syndrome in England and Wales.

Authors:  D E Mutton; E Alberman; R Ide; M Bobrow
Journal:  BMJ       Date:  1991-11-23

3.  Monitoring trends in prenatal diagnosis of Down's syndrome in England and Wales, 1989-92.

Authors:  J K Morris; D E Mutton; R Ide; E Alberman; M Bobrow
Journal:  J Med Screen       Date:  1994-10       Impact factor: 2.136

4.  Translocation Down syndrome in Ohio 1970-1981: epidemiologic and cytogenetic factors and mutation rate estimates.

Authors:  L H Pulliam; C A Huether
Journal:  Am J Hum Genet       Date:  1986-09       Impact factor: 11.025

5.  Mosaic mongolism.

Authors:  B W Richards
Journal:  J Ment Defic Res       Date:  1969-03

6.  The frequency of trisomy and translocation in Down's syndrome.

Authors:  S W Wright; R W Day; H Muller; R Weinhouse
Journal:  J Pediatr       Date:  1967-03       Impact factor: 4.406

7.  Investigation of 142 mosaic mongols and mosaic parents of mongols; cytogenetic analysis and maternal age at birth.

Authors:  B W Richards
Journal:  J Ment Defic Res       Date:  1974-09

8.  Sex ratio in Down syndrome.

Authors:  J Nielsen; P Jacobsen; M Mikkelsen; E Niebuhr; K Sorensen
Journal:  Ann Genet       Date:  1981

9.  How much difference does chromosome banding make? Adjustments in prevalence and mutation rates of human structural cytogenetic abnormalities.

Authors:  E B Hook; N P Healy; A M Willey
Journal:  Ann Hum Genet       Date:  1989-07       Impact factor: 1.670

Review 10.  Epidemiology of trisomy 21: population, peri- and antenatal data.

Authors:  M Mikkelsen
Journal:  Hum Genet Suppl       Date:  1981
View more
  28 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down's syndrome and cryptorchidism.

Authors:  Michele Salemi; Giusi A Longo; Sandro La Vignera; Corrado Romano; Rosita A Condorelli; Carmelo Romano; Paolo Bosco; Enzo Vicari; Aldo E Calogero
Journal:  Neurol Sci       Date:  2012-07-08       Impact factor: 3.307

3.  On the paternal origin of trisomy 21 Down syndrome.

Authors:  Maj A Hultén; Suketu D Patel; Magnus Westgren; Nikos Papadogiannakis; Anna Maria Jonsson; Jon Jonasson; Erik Iwarsson
Journal:  Mol Cytogenet       Date:  2010-02-23       Impact factor: 2.009

4.  Increasing total prevalence rate of cases with Down syndrome in Hungary.

Authors:  Julia Métneki; Andrew E Czeizel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  The National Down Syndrome Project: design and implementation.

Authors:  Sallie B Freeman; Emily G Allen; Cindy L Oxford-Wright; Stuart W Tinker; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

6.  Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome.

Authors:  Sheng-Wen Shaw; Chih-Ping Chen; Po-Jen Cheng; Tzu-Hao Wang; Jia-Woei Hou; Cheng-Tao Lin; Shuenn-Dhy Chang; Hsiao-Lin Hwa; Ju-Li Lin; An-Shine Chao; Yung-Kuei Soong; Fon-Jou Hsieh
Journal:  J Hum Genet       Date:  2007-12-12       Impact factor: 3.172

7.  Down syndrome and microRNAs.

Authors:  Aldina Brás; António S Rodrigues; Bruno Gomes; José Rueff
Journal:  Biomed Rep       Date:  2017-11-17

8.  The male excess in Down's syndrome.

Authors:  W H James
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

Review 9.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

10.  Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects.

Authors:  Emily Graves Allen; Sallie B Freeman; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman
Journal:  Hum Genet       Date:  2008-12-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.